These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 171132)

  • 21. [Bartter's syndrome. Primary renal hyperprostaglandinism].
    Smiley JW; Del Guercio ET; March NM; Hornych A
    J Urol Nephrol (Paris); 1977 Sep; 83(9):693-9. PubMed ID: 926231
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
    Vierhapper H; Waldhäusl W
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bartter's syndrome--case report.
    Miyoshi A; Makino H; Hiramatsu M; Takahashi K; Yamane Y; Takahara J; Suzuki S; Ota Z; Ofuji T; Takehisa Y
    Acta Med Okayama; 1979 Aug; 33(4):305-14. PubMed ID: 158951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
    Cunningham RJ; Brouhard BH; Berger M; Petrusick T; Travis LB
    Pediatrics; 1979 May; 63(5):754-6. PubMed ID: 440896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new syndrome: angiotensin-converting enzyme dysfunction syndrome: differential diagnosis and pathogenesis--case reports.
    Umeki S; Terao A; Sawayama T
    Angiology; 1988 Jan; 39(1 Pt 1):58-67. PubMed ID: 3277490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary kallikrein excretion in Bartter's syndrome.
    Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
    Simatupang TA; Radó JP; Boer P; Geyskes GG; Vos J; Dorhout Mees EJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
    Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bartter's syndrome. Current prospects of nosographic classification and new therapeutic possibilities].
    Cordone G; Fasce L; Gianfranceschi P; Delucchi M; Iester A; Torcia R
    Minerva Pediatr; 1978 Jul; 30(13):1097-104. PubMed ID: 672851
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chronization by indomethacin of the circadian rhythm of blood renin and aldosterone in a case of Bartter's syndrome].
    Cugini P; Lucia P; Murano G; Letizia C; Panichi G; Adone G; Vetere AM; Magnanelli S
    Minerva Urol Nefrol; 1985; 37(1):23-7. PubMed ID: 3901335
    [No Abstract]   [Full Text] [Related]  

  • 33. Bartter's syndrome. Differentiation into two clinical groups.
    Robson WL; Arbus GS; Balfe JW
    Am J Dis Child; 1979 Jun; 133(6):636-8. PubMed ID: 35973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some observations on the pathogenesis of Bartter's syndrome.
    Modlinger RS; Nicolis GL; Krakoff LR; Gabrilove JL
    N Engl J Med; 1973 Nov; 289(19):1022-4. PubMed ID: 4355057
    [No Abstract]   [Full Text] [Related]  

  • 35. A first report: living related kidney transplantation on a patient with Bartter's syndrome.
    Takahashi M; Yanagida N; Okano M; Ishizaki A; Meguro J; Kukita K; Tamaki T; Yonekawa M; Kawamura A; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1588. PubMed ID: 8658796
    [No Abstract]   [Full Text] [Related]  

  • 36. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood pressure fall by angiotensin II antagonist in patients with Bartter's syndrome.
    Kono T; Oseko F; Shimbo S; Nanno M; Ikeda F
    J Clin Endocrinol Metab; 1976 Sep; 43(3):602-5. PubMed ID: 956346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of low salt plus upright posture, angiotensin II, ACTH, and potassium upon plasma renin activity, aldosterone, and cortisol (author's transl)].
    Saruta T; Kondo K; Saito I; Misumi J; Nakamura R; Kidokoro S; Matsuki S
    Nihon Naibunpi Gakkai Zasshi; 1975 Sep; 51(9):740-4. PubMed ID: 182565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
    Stowasser M; Gordon RD; Klemm SA; Tunny TJ
    J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of a girl with the neonatal form of Bartter's syndrome.
    Nakagawa Y; Toya K; Natsume H; Nasuda K; Takeuchi H; Kubota A; Ogawa H; Igarashi Y
    Endocr J; 1997 Apr; 44(2):275-81. PubMed ID: 9228463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.